Results 221 to 230 of about 1,322,584 (361)
Racial/ethnic variations in substance-related disorders among adolescents in the United States.
Li-Tzy Wu +4 more
semanticscholar +1 more source
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo +9 more
wiley +1 more source
Substance-related disorders and somatic symptoms: how should clinicians understand the associations?
K. Yoshimasu
semanticscholar +1 more source
Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study
ABSTRACT Objective To evaluate whether add‐on memantine would exacerbate seizures in people with epilepsy. Methods This was a prospective cohort study. People with epilepsy diagnosed with cognitive impairment were consecutively invited. Those who agreed were followed up for at least 24 weeks.
Peiyu Wang +7 more
wiley +1 more source
Substance-related disorders among juvenile offenders: what role do psychopathic traits play?
E. Kimonis, J. R. Tatar, E. Cauffman
semanticscholar +1 more source
Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study
ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew +11 more
wiley +1 more source
Top-Accessed Article: UV Light Tanning as a Type of Substance-Related Disorder [PDF]
Elizabeth K. Farhat
openalex +1 more source

